Trials / Completed
CompletedNCT01575288
Oral Trehalose Therapy to Reverse Arterial Aging in Middle-Aged and Older Adults
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 110 (actual)
- Sponsor
- University of Colorado, Boulder · Academic / Other
- Sex
- All
- Age
- 50 Years – 79 Years
- Healthy volunteers
- Accepted
Summary
The proposed study will assess the ability of a naturally occurring sugar to improve the function of arteries with age. Overall, the proposed research project has the long-term potential to influence clinical practice guidelines by establishing a novel, easy to deliver, cost-effective therapy for treating age-associated arterial dysfunction and reducing the risk of cardiovascular disease with age.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Placebo | 100g maltose 1/day |
| DRUG | High-dose trehalose | 100g 1/day |
Timeline
- Start date
- 2012-05-01
- Primary completion
- 2015-12-01
- Completion
- 2015-12-01
- First posted
- 2012-04-11
- Last updated
- 2015-12-11
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01575288. Inclusion in this directory is not an endorsement.